Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis ( NE(r) after induction withmitoxantrone...)

HOME >> MEDICINE >> TECHNOLOGY

Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

NE(r) after induction with mitoxantrone remained safe and effective throughout the treatment period.

These new findings were presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) along with new confirming MRI findings from the 15-month study, which showed that the decreases in clinical and MRI markers of disease activity, were accompanied by favorable effects on disease burden and irreversible brain tissue damage as shown by significant decreases in the accumulation of lesion load, and significant reduction in the proportion of lesions evolving into chronic black holes.

"This combination therapy is emerging as a promising treatment option for patients who have active RRMS, or who are not responding optimally to traditional first-line therapies," said Tim Vollmer, M.D., Director, Neuroimmunology Program, Barrow Neurological Institute at St. Joseph's Hospital and Medical Center and the primary investigator in this study. "This study builds on earlier studies that demonstrate the effect of COPAXONE(r) on disease activity and inflammation in the central nervous system of RRMS patients," he added.

Data analysis surrounding the mode of action of this novel treatment strategy was also presented at the AAN, in which researchers attributed the benefit of the combination of therapies to the combined anti-inflammatory effect of COPAXONE(r) and mitoxantrone.

-more-

GA Mitoxantrone Combination/Page 2

"These data shed new light on the concept of treating MS by first suppressing the auto-aggressive immune system with an immunosuppressant, and then favorably modifying its activity with an immunomodulator such as COPAXONE(r)," said Amit Bar-Or, M.D., FRCPC, assistant professor, Director of the Experimental Therapeutics at the Montreal Neurological Institute (MNI) and primary investigator of the immunological study.

About the Analyses

The analysis, Reductions in MRI Disease Activity and Relapse Rates Ob
'"/>

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer

Post Your Comments:

(Date:11/25/2009)...K,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechn...amthatstopsseverebleeding,wonfirstprizeand$10,000i...curityChallenge2009,companyofficialsannouncetoday....world,Remedium,steampitchedtheirinventionattheGSCS...ness. ,, Remedium( www.remediumtechnologies.com...

(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., UnitedStatesDentalDevicesMarketAnalysisandFor...0158733/United-States-Dental-Devices-Market-Analys...entalDevicesMarketAnalysisandForecaststo2015 ,,...n-depthinformationanddatarelatingtotheUSdentaldevi...

(Date:11/25/2009)...ss.,Nov.25/PRNewswire/--AccordingtoMillenniumResea...ymarketintelligence,thenearly$3billionUSmarketfort...erthenextfiveyearsdespitetherecenteconomicslowdown...thatthismarketwillremainhighlydynamicoverthenextfi...esinpreviouslyunderservedsegmentsofthetraumafixati...

[0] Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam [0] Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 [0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown

...c. 13 - The Michael J. Fox,Foundation for Parkinso...search toward therapies to alleviate Parkinson,s-r...he funding is to be awarded under a new,initiative...on,s Disease,made possible by generous leadership ...rica), affiliates of Merck KGaA, Darmstadt, German...

...., Dec. 12 Solvay Pharmaceuticals, Inc.,announced...ely with the,U.S. Food and Drug Administration (FD...s of the Cardio-Renal Advisory Committee in its me...id conversion of recent onset,atrial fibrillation ...d against approval of tedisamil, at this time,requ...

Other Medicine Technology:MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 2 MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 3 MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 4 Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation 2

MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation

(Date:11/25/2009)...can occur in children with autism and related cond...ncludes medication combined with a structured trai...sity researchers and their colleagues. , Publis...the American Academy of Child and Adolescent Psych...stitute of Mental Health (NIMH) Research Units on ...

(Date:11/25/2009)...Imaging Services, known as one of the largest inde... equipment, now offering a total solution for diag...vice and installation with acquisition of Kosmic M...lifornia) , Brick, NJ (PR...ces is proud to announce its acquisition of Kosmic...

(Date:11/25/2009)...FirstCall/--TheAdvisoryBoardCompany(Nasdaq: ABCO )...PiperJaffrayHealthCareConferenceinNewYorkCity.Spea...willbetheCompany,sChiefExecutiveOfficer,RobertW.Mu...haelT.Kirshbaum.Thepresentationmaterialswillbeavai...soryboardcompany.com ,throughDecember16,2009. ,...

(Date:11/25/2009)...e/--dazzlesmile,llc www.dazzlesmile.com andOptimal...efileda67-pagefederallawsuitagainstEpicAdvertising...dServicesLimited,andAtLastFulfillment.The13-countC...heDistrictofUtah,allegesmassivenationalconsumerfra...eningproducts,violationsoftheRacketeeringInfluence...

(Date:11/25/2009)...sstoImproveOverallOutcomesforLungCancer ,, WA...ngCancerAlliance-California(LCA-CA)issuedits2ndAnn...ssessmentofprogressbeingmadeagainstthislethaldisea...cerAlliance(LCA),theonlynationalorganizationdedica...livingwithoratriskforlungcancer. ,, (Photo: htt...

Breaking Medicine News(10 mins):Health News:Parent training key to improved treatment of behavior problems in children with autism 2 Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2 Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3 Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2 Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2

[0] Parent training key to improved treatment of behavior problems in children with autism [0] Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) [0] The Advisory Board Company to Present at 21st Annual Piper Jaffray Health Care Conference [0] dazzlesmile Sues Epic Advertising and Jesse Willms [0] Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer

...IEGO, March 31 Triage Wireless, Inc. today,announ...vestment round led,by Qualcomm Ventures. Other par...s Sanderling Ventures and 3i Group and new investo...less vital signs,monitoring system, OmniScan(R), w...

...ly Allowance for Personal Care Home Residents Not ...ennsylvania residents of personal care homes livin... In return, they receive a personal needs,allowanc...ersonal care home residents will rally for a PNA,i...

...ion,s newest disposable laparoscopic instruments w... during laparoscopic procedures while, delivering ...- a first in the healthcare...ing surgeries while simultaneously delivering incr...

...2007 Revenues Increased 89.39% to $15.91 million. ...8 million., - FY 2007 Net Income was $6.12 millio...econference to Be Held at 9:00 a.m. EST Today -, ...vider in the nutraceutical industry engaged in the...

...h Tips, Blogs and Video Available at dietchallenge...March 31,USA TODAY will kick of its fifth annual U...ies will run every Monday in print and on, http://...ir waistlines. These,stories range from a man in G...

...rs debate worth of lipid-lowering agent that combi...althDay News) -- A divided cardiology community is...g that a drug can lower levels of "bad" LDL choles...known statin -- simvastatin -- with ezetimibe, whi...

Triage Wireless Raises $20.3 Million in Series B Financing Round Led by Qualcomm Ventures Mental Health Advocates Rally to 'Raise the $60'Encision Moves Power and Safety to Surgeons' Fingertips China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features Cholesterol Drug Controversy Continues

...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...

Medicine Products:

Estrogens, Serum Fractionated Escitalopram, Serum/Plasma Erythrocyte Porphyrin (EP), Whole Blood Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG

( NE(r) after induction withmitoxantrone...)Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis,Health